2018
DOI: 10.1016/j.ygyno.2018.05.023
|View full text |Cite|
|
Sign up to set email alerts
|

An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 65 publications
0
4
0
Order By: Relevance
“…Based on clinical and histopathological criteria, it is classified in two subtypes. Endometrioid adenocarcinoma (Type I), which accounts for about 80% of cases, is low-grade, estrogen-dependent and usually associated with complex and atypical endometrial hyperplasia, whereas type II endometrial carcinoma include serous papillary and clear cell types and is more aggressive and estrogen-independent [116,117]. For the general pathogenesis and progression of cancer, changes in cell–cell contacts have been described to play an essential role [118,119,120].…”
Section: Direct Cell–cell Interactions In Endometrial Pathophysiologymentioning
confidence: 99%
“…Based on clinical and histopathological criteria, it is classified in two subtypes. Endometrioid adenocarcinoma (Type I), which accounts for about 80% of cases, is low-grade, estrogen-dependent and usually associated with complex and atypical endometrial hyperplasia, whereas type II endometrial carcinoma include serous papillary and clear cell types and is more aggressive and estrogen-independent [116,117]. For the general pathogenesis and progression of cancer, changes in cell–cell contacts have been described to play an essential role [118,119,120].…”
Section: Direct Cell–cell Interactions In Endometrial Pathophysiologymentioning
confidence: 99%
“…Several immunohistochemical markers are currently considered representative of a specific tissue or organ. However, many of these markers could be expressed in variable percentages also in different types of tumors, originating from different sites (6). This overlap represents the main challenge in the clinical application of immunohistochemistry within the diagnostic work-up of distant metastases.…”
Section: Introductionmentioning
confidence: 99%
“…Complex systems—like human tissues, although being made of cells of similar structure, origin, metabolism and functionality, show a large morphological and physiological diversity. The mechanisms leading to disordering in life functions and the growth of cells of such tissues are intensively studied, because they can affect the progress of understanding the diseases (including cancer) and the formation of body dysfunctions 29 , 30 . It is known that a change of the functionality of cells is accompanied by a chemical change in their environment and a change in their structure.…”
Section: Introductionmentioning
confidence: 99%